NIMML Awards Monica Viladomiu a Doctorate in Genetics, Bioinformatics and Computational Biology


Blacksburg, VA, June 23rd, 2015 - Dr. Viladomiu joined the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) at Virginia Tech in 2010 for an internship. She was accepted in the Genetics, Bioinformatics and Computational Biology (GBCB) program in 2011.

“Dr. Viladomiu has characterized novel mechanisms of immunoregulation underlying immune responses to gut pathogens. Having worked with Dr. Viladomiu in my role of Director of NIMML for the last 5 years, I have no doubt that she will be a very effective researcher at the newly established Jill Roberts Institute for Research in Inflammatory Bowel Disease , in the Division of Gastroenterology and Hepatology at the Weill-Cornell Medical College in New York City” Said Dr. Josep Bassaganya-Riera, Professor of Immunology and Director of NIMML.

“Monica is graduating NIMML with over 20 publications related to developing new inflammatory bowel disease therapeutics, characterizing immune responses to H. pylori and C. difficile. Dr. Viladomiu exemplifies the mission, vision and values of NIMML by conducting immunology and informatics research that accelerates the path to cures for devastating and widespread diseases. This research will ultimately lead to the development of disruptive therapeutics for infectious and immune-mediated diseases” Said Dr. Hontecillas, Associate Professor of Immunology and Co-Director of NIMML.

Dr. Viladomiu earned her B.S. in Biotechnology from the University of Vic, Spain, and her PhD in Genetics, Bioinformatics and Computational Biology under the direction of Dr. Bassaganya-Riera from Virginia Tech in 2015. She received training in mucosal immunology, nutritional immunology, bioinformatics, and computational modeling of immunological processes in infectious and immune-mediated diseases.

About NIMML

The NIMML Institute is a 501 (c) (3) non-profit public charity foundation focused on a transdisciplinary, team-science approach to precision medicine at the interface of immunology, inflammation, and metabolism. The NIMML Institute team has led numerous large-scale transdisciplinary projects and is dedicated to solving important societal problems by combining the expertise of immunologists, computational biologists, toxicologists, modelers, translational researchers, and molecular biologists. The Institute is headquartered in Blacksburg, VA. For more information, please visit www.nimml.org or contact pio@nimml.org.